SCHEMBL22358971

SCHEMBL22358971

NC(=O)C1CN(CC2CCNCC2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 3/20 0.49
ARG1 P05089 1/20 0.41
ARG2 P78540 1/20 0.41
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
CYP2D6 P10635 1/20 0.39
CACNA2D1 P54289 1/20 0.39
CACNA1B Q00975 1/20 0.39
CACNB1 Q02641 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
PARP1 P09874 1/20 0.37
GABRA5 P31644 3/20 0.36
GABRB2 P47870 3/20 0.36
GABRA1 P14867 2/20 0.36
GABRA4 P48169 2/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22359167 0.88 SMN1; SMN2 (0.46) GBA1ARG1ARG2KDM4EMAPT
SCHEMBL1794055 0.87 SMN1; SMN2 (0.44) SMN1; SMN2BCHEGAA
SCHEMBL3580053 0.84 SMN1; SMN2 (0.53) GBA1ARG1ARG2KDM4EMAPT
SCHEMBL22359173 0.83 GBA1 (0.46) GBA1ARG1ARG2CACNA2D1CACNA1B
SCHEMBL22358960 0.82 GBA1 (0.49) GBA1ARG1ARG2CACNA2D1CACNA1B
SCHEMBL22359134 0.80 BCHE (0.45) GBA1KDM4ECACNA2D1CACNA1BCACNB1
SCHEMBL24379284 0.75 GBA1 (0.61) GBA1ARG1ARG2CACNA2D1CACNA1B
SCHEMBL31306568 0.75 GBA1 (0.61) GBA1ARG1ARG2CYP2D6CACNA2D1
SCHEMBL22359132 0.75 OPRK1 (0.38) GBA1ARG1ARG2KDM4EMAPT
SCHEMBL30584851 0.75 SMN1; SMN2 (0.50) KDM4EMAPTKMT2AATMCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020167518-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2020-08-20 WO disclosed